French Health Insurtech Alan Raises $116 Million at $5.83 Billion Valuation

Alan, the French digital health insurance company, has raised $116 million in fresh funding at a valuation of $5.83 billion, cementing its position as one of Europe's most valuable insurtech firms. The capital injection is earmarked for continued artificial intelligence investment, international growth, and further expansion of the company's health insurance and healthcare services platform.

Founded in France, Alan has built a digitally-native health insurance model that combines insurance coverage with integrated healthcare services, telehealth, and AI-powered member tools — a vertically integrated approach that distinguishes it from traditional health insurers. The company has expanded beyond its home market into other European countries, including Belgium and Spain, building a pan-European health insurance platform aimed at both individual members and corporate clients seeking modern employee health benefits.

The $5.83 billion valuation is particularly notable in the context of the broader venture capital and insurtech funding environment, which has been more selective and disciplined than during the funding boom of prior years. Alan's ability to raise substantial capital at a premium valuation signals sustained investor conviction in the long-term thesis for digital health insurance — namely that incumbent health insurers are vulnerable to disruption by technology-first competitors that can deliver better member experiences, more efficient operations, and integrated care models at scale. The funding round reflects a flight to quality within insurtech, where investors are concentrating capital in proven, well-capitalised platforms with clear paths to profitability rather than spreading investment across early-stage experiments.

Alan's raise comes amid a wave of insurtech and fintech funding activity in Europe. Irish insurtech Kayna secured EUR 1.5 million in seed funding to expand embedded insurance for vertical SaaS platforms in the UK and US, illustrating continued investor interest in the embedded insurance model. These developments suggest that while the insurtech funding market has matured and become more selective, capital continues to flow to companies with differentiated technology, clear business models, and demonstrated traction.

The health insurance segment is a particularly attractive target for insurtech innovation given its scale and growth: health was the fastest-growing global insurance segment in 2025 at 12.3% according to Allianz, driven by rising medical costs and growing demand for private healthcare protection. Alan's AI investment focus aligns with the broader industry shift toward deploying artificial intelligence across underwriting, claims processing, and member engagement. For the European health insurance market, Alan represents both a competitive threat to incumbents and a demonstration of how technology-first models can capture share in one of insurance's most dynamic segments. The company's continued growth and premium valuation will be closely watched as a barometer for the viability of digitally-native insurance models across Europe and beyond.